Skip to main content
Equibles

NORTHERN TRUST CORP

Bank

Position in LPCN — Lipocine Inc.

CIK 73124 CHICAGO, IL
Back to LPCN Full portfolio

Position in LPCN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$40,811
-$63,394 QoQ
Shares Held
15,942
+22.2% QoQ
Ownership
0.193%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 36 holders
Holding Since
Mar 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LPCN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORTHERN TRUST CORP holds $7,872,952,300 across 424 Biotechnology names. LPCN ranks #385 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 2,486,478 $1,235,108,212
2 REGN
Regeneron Pharmaceuticals, Inc.
 916,467 $571,453,829
3 ALNY
Alnylam Pharmaceuticals, Inc.
 886,900 $266,983,504
4 RPRX
Royalty Pharma plc
 4,718,859 $264,586,419
5 RVMD
Revolution Medicines, Inc.
 1,117,110 $209,212,357
6 MRNA
Moderna, Inc.
 2,985,329 $209,062,587
7 INCY
Incyte Corp
 1,761,966 $199,736,460
8 CYTK
Cytokinetics Inc
 1,647,345 $140,337,319

All Filings in LPCN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $40,811 15,942
2026-03-31 $104,205 13,042
2025-12-31 $105,674 13,160
2025-09-30 $37,506 13,160
2025-06-30 $41,585 13,160
2025-03-31 $41,848 13,160
2024-12-31 $64,220 13,160
2024-09-30 $59,088 13,160
2024-06-30 $108,438 13,160
2023-03-31 $51,071 160,603
2022-12-31 $63,919 160,603
2022-09-30 $72,271 160,603
2022-06-30 $128,643 160,603
2022-03-31 $230,468 168,225
2021-12-31 $166,710 168,225
2021-09-30 $183,742 168,571
2021-06-30 $242,363 173,117
2021-03-31 $223,815 148,222
2020-12-31 $168,925 124,210
2020-09-30 $124,756 88,480
2020-06-30 $72,133 57,249
2020-03-31 $23,864 49,717